Evidence map›Paper›PMID 40202182›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Oxidative Rearrangements of the Alkaloid Intermediate Geissoschizine.

Mohamed O Kamileen, Benke Hong, Klaus Gase, Maritta Kunert, Lorenzo Caputi, Benjamin R Lichman, Sarah E O'Connor

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Oxidative Rearrangements of the Alkaloid Intermediate Geissoschizine.Angewandte Chemie (International ed. in English) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohamed O Kamileen *Department of Natural Product Biosynthesis, Max Planck Institute for Chemical Ecology, D-07745, Jena, Germany.
Benke Hong *Department of Natural Product Biosynthesis, Max Planck Institute for Chemical Ecology, D-07745, Jena, Germany.
Klaus GaseDepartment of Natural Product Biosynthesis, Max Planck Institute for Chemical Ecology, D-07745, Jena, Germany.
Maritta KunertDepartment of Natural Product Biosynthesis, Max Planck Institute for Chemical Ecology, D-07745, Jena, Germany.
Lorenzo CaputiDepartment of Natural Product Biosynthesis, Max Planck Institute for Chemical Ecology, D-07745, Jena, Germany.
Benjamin R LichmanCentre for Novel Agricultural Products, Department of Biology, University of York, York, YO10 5DD, UK.
Sarah E O'ConnorDepartment of Natural Product Biosynthesis, Max Planck Institute for Chemical Ecology, D-07745, Jena, Germany.

Funding

Max Planck Institute for Chemical Ecology
6 · The paper itself

Abstract

Plants can generate structural diversity by enzymatic rearrangement of a central intermediate. 19E-geissoschizine is one such chemically versatile intermediate that plays a central role in the biosynthesis of monoterpene indole alkaloids such as strychnine, ibogaine, and vinblastine. Here we report how 19E-geissoschizine undergoes oxidative transformations to generate four distinct alkaloid scaffolds through the action of three biosynthetic enzymes. Using in vitro enzymatic assays and gene silencing, we demonstrate how these three cytochrome P450 enzymes in the medicinal plant Catharanthus roseus transform 19E-geissoschizine into strychnos, sarpagan, akuammiline-type, and mavacurane-type alkaloids. We use mutational analysis to show how minimal changes to the active site of these similar enzymes modulate product specificity. This work highlights how substrate reactivity and enzyme mutations work synergistically to generate chemical diversity.

Indexed as

AlkaloidsIndole AlkaloidsCatharanthusCytochrome P-450 Enzyme SystemMolecular StructureOxidation-ReductionAlkaloidsCytochrome P-450 Enzyme SystemIndole AlkaloidsBiosynthesisEnzymesGeissoschizineNatural productsPlant P450s

Identifiers

PMID40202182
PMCPMC12144881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.